Certara, Inc. (CERT) earnings date
Feb 24, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 37 days, typically, give or take 10 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 5, 2026 | before open | 36 | 8-K |
| Q2 FY2026 | Tue, Aug 4, 2026 | before open | 35 | 8-K |
| Q1 FY2026 | Mon, May 11, 2026 | before open | 41 | 8-K |
| Q4 FY2025 | Thu, Feb 26, 2026 | before open | 57 | 8-K |
| Q3 FY2025 | Thu, Nov 6, 2025 | after close | 37 | 8-K |
| Q2 FY2025 | Wed, Aug 6, 2025 | after close | 37 | 8-K |
| Q1 FY2025 | Mon, May 5, 2025 | after close | 35 | 8-K |
| Q4 FY2024 | Wed, Feb 26, 2025 | after close | 57 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 Certara Reports Third Quarter 2026 Financial Results Certara delivers a solid quarter with double-digit software revenue growth Updates 2026 financial outlook Appoints Grant Peterson Chief Product Officer Company to host conference call and webcast today at 8:30 a.m. ET RADNOR, PA — November 5, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its third quarter 2026 financial results." exhibit |
| Q3 FY2026 | "See note (2) in the section titled “A Note on Non-GAAP Financial Measures” below for more information on adjusted net income and adjusted diluted earnings per share. 3 THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2026 2025 2026 2025 Key Financials (in millions, except per share data) Revenue $ 94.9 $ 90.9 $ 282.3 $ 275.3 Software revenue $ 48.8 $ 43.8 $ 147.4 $ 136.9 Services revenue $ 46.1 $ 47.1 $ 134.9 $ 138.4 Total bookings $ 92.5 $ 88.6 $ 288.0 $ 284.4 Software bookings $ 46.9 $ 40.8 $ 146.3 $ 128.1 Services bookings $ 45.6 $ 47.8 $ 141.6 $ 156.2 Net income (loss) fro" exhibit |
| Q3 FY2026 | "Adjusted EBITDA Margin: The Company's previously communicated full-year 2026 adjusted EBITDA margin outlook was 29% to 31%." exhibit |
| Q3 FY2026 | "Adjusted Diluted Earnings Per Share: The Company is updating its expected full-year adjusted diluted earnings per share range to $0.31 to $0.34." exhibit |
| Q3 FY2026 | "The outlook reflects continuing operations and excludes the Regulatory and Medical Writing business, which was divested on May 8, 2026, and is reported as discontinued operations." exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, PA — August 4, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its second quarter 2026 financial results." exhibit |
| Q2 FY2026 | "“We continue to expect full-year revenue growth of 0% to 4% on a comparable continuing operations basis, supported by continued strength in software and improving services performance as we move through the second half of the year.”" exhibit |
| Q2 FY2026 | "THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2026 2025 2026 2025 Key Financials (in millions, except per share data) Revenue $ 93.3 $ 92.4 $ 187.4 $ 184.5 Software revenue $ 48.8 $ 46.7 $ 98.5 $ 93.1 Service revenue $ 44.5 $ 45.7 $ 88.8 $ 91.4 Total bookings $ 98.3 $ 97.4 $ 195.5 $ 195.7 Software bookings $ 50.7 $ 46.6 $ 99.4 $ 87.3 Services bookings $ 47.6 $ 50.8 $ 96.1 $ 108.4 Net income (loss) $ (6.1) $ 1.5 $ (17.9) $ 3.0 Diluted earnings (loss) per share $ (0.04) $ 0.01 $ (0.11) $ 0.02 Adjusted EBITDA $ 26.2 $ 27.0 $ 52.9 $ 55.4 Adjusted net income $ 12.5 $ 12.7 $ 21.6 $ 29.5 Adju" exhibit |
| Q2 FY2026 | "Full year 2026 adjusted EBITDA margin for Continuing Operations, excluding the Regulatory and Medical writing business, is expected to be approximately 29% to 31%." exhibit |
| Q2 FY2026 | "Full year adjusted diluted earnings per share for Continuing Operations, excluding the Regulatory and Medical Writing business is expected to be in the range of $0.31 to $0.36." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CERT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CERT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CERT/"><img src="https://veritasdata.dev/embed/CERT.svg" alt="CERT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CERT/)
Script
<script async src="https://veritasdata.dev/embed/CERT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CERT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.